Basic Information
Basic information for LINC01278-213-49aa
Peptide Name LINC01278-213-49aa
Genome Position chrX:63427218-63427364[-]
Species Human
Peptide Sequence MGVPFLLKLPSYPHPPYVSAEPTLIQPTPQWWDRFPSPYVVLFLPLHSL
Peptide Length 49
Unique No (LINC01278-202-49aa,LINC01278-204-49aa,LINC01278-205-49aa,LINC01278-219-49aa,LINC01278-235-49aa,LINC01278-238-49aa)
Grand Average of Hydropathicity 0.1367
Relative Molecular Mass 6538.43
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235437;LINC01278
Transcript ID/Name ENST00000656972;LINC01278-213
Transcript Length 2952
Coding Ability 0.4695
DNA Sequence Corresponding to Peptide ATGGGGGTACCATTTCTACTCAAACTTCCTTCATATCCCCACCCCCCTTATGTCTCAGCCGAACCTACCCTAATCCAGCCCACGCCACAATGGTGGGACAGGTTCCCCAGTCCCTATGTGGTCTTATTTTTACCCTTGCACTCCCTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :